Clinical Trials

48 enrolled

Nasopharyngeal Carcinoma

NCT00957086 2024-01-09

Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer

Phase 3 Unknown

710 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03620032 2023-12-06

DIPG

54 enrolled

CNS

Diffuse Intrinsic Pontine Glioma

NCT06022276 2023-09-01

Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors

Phase NA Unknown

46 enrolled

Other solid neoplasm

Solid Tumor

NCT05606263 2023-05-26

GCR-05

55 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03574402 2022-12-06

TRUMP

400 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03837808 2022-11-07

Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma

Phase 3 Unknown

384 enrolled

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

NCT04367909 2021-11-08

A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma

68 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05024019 2021-08-27

Nimotuzumab Combined With Radiotherapy in High-risk Patients With HNSCC Not Suitable for Cisplatin After Surgery

95 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03766178 2021-07-07

Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

45 enrolled

Esophageal Squamous Cell Carcinoma

NCT04882462 2021-05-12

Carpp-1

100 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04833205 2021-04-20

Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer

30 enrolled

CNSThoracic

Lung Neoplasms, Meningeal Carcinomatosis

NCT03557112 2018-11-02

By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPC

180 enrolled

Nasopharyngeal Carcinoma

NCT03469531 2018-08-13

Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

100 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Neoplasms

NCT03400592 2018-01-17

NIEGA

55 enrolled

Stomach Neoplasms

NCT02945267 2016-10-26

Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer

Phase 4 Unknown

60 enrolled

Pancreatic Neoplasms

NCT02705612 2016-03-10

Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer

60 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT01393080 2016-02-17

NSCLC

Phase NA Unknown

160 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01074021 2015-10-30

Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer

Phase 3 Unknown

480 enrolled

Nasopharyngeal Neoplasms

NCT01232374 2015-08-20

Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma

144 enrolled

Tumor-Agnostic

Carcinoma, Squamous Cell

NCT02293356 2015-08-19

Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma

Phase 4 Unknown

2,000 enrolled

Nasopharyngeal Carcinoma

NCT02395068 2015-08-19

Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors

Phase 1 Unknown

40 enrolled

Other solid neoplasm

Solid Tumors

NCT01861223 2014-02-25

Afatinib Plus Nimotuzumb for NSCLC

Phase 1/2 Unknown

50 enrolled

Thoracic

NSCLC

NCT01993784 2013-11-25

Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma.

Phase 1/2 Unknown

9 enrolled

Esophageal Squamous Cell Carcinoma

NCT01516996 2012-03-20

Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer

80 enrolled

Hypopharyngeal Neoplasms, Oropharyngeal Neoplasms

NCT01402180 2011-07-26

Nimotuzumab

Phase 2/3 Unknown

128 enrolled

Esophageal Squamous Cell Carcinoma

NCT01336049 2011-04-15

Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer

70 enrolled

Esophageal Squamous Cell Carcinoma

NCT00972465 2009-09-07

Study of Nimotuzumab to Treat Colorectal Cancer

48 enrolled